Vivo Capital related stories
All articles and analysis
PatientPop reels in $50m Series CSanta Monica, California-based PatientPop, a platform for smaller medical practices, has raised $50 million in Series C funding.
- ESSA Pharma snags $49m in funding, Pfizer among the investors
Vancouver, British Columbia-based ESSA Pharma secured US$49 million in a public offering that included investments by the pharmaceutical company's venture capital backers.
- VC-backed ALX Oncology goes public
Burlingame, California-based ALX Oncology Holdings Inc, a immuno-oncology company, has raised $161.5 million for its IPO after pricing its 8.5 million shares at $19 per share.
Tranquis Therapeutics rakes in $30m Series ATranquis Therapeutics, a private immuno-neurology company, has raised $30 million in Series A funding.
- Bolt Biotherapeutics rakes in $93.5m Series C
Redwood City, California-based Bolt Biotherapeutics Inc, a biotechnology company, has raised $93.5 million in Series C financing.
- Legend racks up $150.5m Series A
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, has raised $150.5 million in Series A financing.
RemeGen lands $100mRemeGen, a Chinese biopharmaceutical company, has raised $100 million in financing.
- Tarsus Pharmaceuticals takes in $60 mln Series B
Irvine, California-based Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, has secured $60 million in Series B financing.
Arizona PSPRS sees benefits to playing VC lotteryThe Phoenix pension fund also plans to expand its co-investment program from 10 to 20 percent.